EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cephaeline promotes ferroptosis in breast cancer via p53/SLC7A11/GPX4 axis

Xiaohong Li, Jinghan Yu, Beibei Lin, Yudiao Gong

DARU Journal of Pharmaceutical Sciences · 19.06.2026 · 34 (2)

DOI: 10.1007/s40199-026-00619-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift DARU Journal of Pharmaceutical Sciences, online erschienen am 19.06.2026. Verfasst von Xiaohong Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: The People's Hospital of Cangnan, The Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Phytogenic, Breast Neoplasms, Ferroptosis, Cephaelis. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The science and technology project of Cangnan County.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cephaeline (CPL), a bioactive compound derived from the medicinal plant Ipecacuanha, has demonstrated inhibitory effects on several tumor types. Nevertheless, its role in breast cancer and the underlying molecular mechanisms remain largely unexplored.

Objectives

This research aimed to investigate the anti-cancer potential of CPL in breast cancer cells.

Methods

The IC50 of CPL was determined using the CCK-8 assay. Subsequently, the effects of CPL on cell migration and proliferation were assessed through wound healing (scratch) and colony formation assays, respectively. Additionally, MDA and GSH levels were quantified using ELISA, while ROS production was visualized via DHE staining. Intracellular iron content was measured using an iron assay kit. Furthermore, the expression levels of p53, SLC7A11, and GPX4 were evaluated using Western blot. All experiments were performed in triplicate and independently repeated at least three times, and data were analyzed using Student’s t-test or one-way ANOVA, as appropriate.

Results

CPL significantly inhibited the proliferation and viability of 4T1 and MDA-MB-231 breast cancer cells in a dose-dependent manner, with IC50 values of 38.89 nM and 50.29 nM, respectively, and concomitantly suppressed cell migration and colony formation at higher concentrations. It also increased intracellular MDA and ROS and downregulated GSH, SLC7A11 and GPX4, inducing ferroptosis. siRNA knockdown of p53 attenuated CPL's effects, indicating p53's key role in CPL's anti-cancer activity.

Conclusions

This study provides evidence that CPL exerts anti-breast cancer effects by promoting ferroptosis through the p53/SLC7A11/GPX4 axis, highlighting its therapeutic potential as a novel agent for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic Agents, PhytogenicBreast NeoplasmsFerroptosisCephaelisPlant ExtractsAnimalsFemaleHumansMiceAmino Acid Transport System y+Cell Line, TumorCell MovementCell ProliferationCell SurvivalMDA-MB-231 CellsPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesTumor Suppressor Protein p53

Stichwörter der Autor:innen

Breast cancerCephaelineFerroptosisP53SLC7A11

Substanzen

Amino Acid Transport System y+Antineoplastic Agents, PhytogenicPhospholipid Hydroperoxide Glutathione PeroxidaseReactive Oxygen SpeciesSLC7A11 protein, humanTP53 protein, humanTumor Suppressor Protein p53Plant Extracts

Autor:innen und Institutionen

  • The People's Hospital of Cangnan, The Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, China.
  • The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Wenzhou Medical University, Lishui, China.
  • The People's Hospital of Cangnan, The Affiliated Cangnan Hospital, Wenzhou Medical University, Wenzhou, China. researcheryudiao@126.com.
  • The Sixth Affiliated Hospital of Wenzhou Medical University, Lishui People's Hospital, Wenzhou Medical University, Lishui, China. researcheryudiao@126.com.

Förderung

  • The science and technology project of Cangnan County

Zitieren

APA

Li, X., Yu, J., Lin, B., & Gong, Y. (2026). Cephaeline promotes ferroptosis in breast cancer via p53/SLC7A11/GPX4 axis. DARU Journal of Pharmaceutical Sciences, 34(2). https://doi.org/10.1007/s40199-026-00619-9

Vancouver

Li X, Yu J, Lin B, Gong Y. Cephaeline promotes ferroptosis in breast cancer via p53/SLC7A11/GPX4 axis. DARU Journal of Pharmaceutical Sciences. 2026;34(2). doi:10.1007/s40199-026-00619-9

BibTeX
@article{Li2026,
  author = {Li, Xiaohong and Yu, Jinghan and Lin, Beibei and Gong, Yudiao},
  title = {Cephaeline promotes ferroptosis in breast cancer via p53/SLC7A11/GPX4 axis},
  journal = {DARU Journal of Pharmaceutical Sciences},
  year = {2026},
  volume = {34},
  number = {2},
  doi = {10.1007/s40199-026-00619-9}
}
Kostenlos starten →